文献速递胸部肿瘤放疗

肿瘤与胸膜接触与早期非小细胞肺癌立体定向消融放疗后区域复发无关

Contact of a tumour with the pleura is not associated with regional recurrence following stereotactic ablative radiotherapy for early stage non-small cell lung cancer.
PubMed 文献 · Radiother Oncol · 2018-12-31

这项回顾性队列研究纳入554例接受立体定向消融放疗(SABR)的早期非小细胞肺癌(NSCLC)患者,其中494例可分析孤立区域复发(IRR)。中位随访48.1个月,21例发生IRR(4%),胸膜接触的存在、类型及长度均与所研究结局无关。

要点

  • 554例接受SABR的早期NSCLC患者中,494例可分析IRR,21例发生IRR(4%)。
  • 胸膜接触的存在和类型与IRR、DR及OS均无关。
  • IRR和DR的1年、2年、5年累积发生率分别为2%、3%、7%和8%、15%、21%,2年OS为71%。

核心结论

  • 作为脏层胸膜侵犯替代指标的胸膜接触的存在、类型和长度均不能预测结局。
  • 作者认为需要进一步研究早期NSCLC中隐匿性淋巴结受累、(孤立)区域复发、远处转移和死亡的危险因素,以制定风险适配的诊断、治疗和随访策略。

研究设计与样本

  • 回顾性队列研究,纳入接受SABR治疗的早期NSCLC患者,以孤立区域复发(IRR)为主要终点,远处复发(DR)和总生存(OS)为次要终点。
  • 生存分析采用累积发生率函数(IRR和DR)或Kaplan-Meier法(OS),单因素和多因素分析采用Cox比例风险模型。
  • 利用SABR计划CT扫描研究肿瘤与胸膜接触的预后影响。

主要发现

  • 共纳入554例患者,其中494例可分析IRR;存活患者中位随访48.1个月。
  • 21例发生IRR(4%)。
  • IRR的1年、2年、5年累积发生率分别为2%、3%、7%;DR分别为8%、15%、21%。
  • 2年OS为71%。
  • 胸膜接触的存在和类型与所研究的任何结局均无关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: The aim was to investigate the incidence of isolated regional failure following stereotactic ablative radiotherapy (SABR) and risk factors for recurrence. MATERIALS AND METHODS: Early stage non-small cell lung cancer (NSCLC) patients treated with SABR were included in this retrospective cohort study, with isolated regional recurrence (IRR) as primary endpoint, distant recurrence (DR) and overall survival (OS) as secondary endpoints. Survival analyses were performed using the cumulative incidence function (IRR and DR) or the Kaplan-Meier method (OS) and Cox proportional hazards modelling for univariate and multivariate analyses. The prognostic effect of contact between the tumour and the pleura was investigated using the CT scans used for SABR planning. RESULTS: A total of 554 patients were included, of whom 494 could be analysed for IRR. The median follow-up for surviving patients was 48.1 months. Twenty-one patients developed an IRR (4%). The cumulative incidence of IRR and DR after 1-, 2-, and 5 years was 2%, 3%, 7% and 8%, 15% and 21%, respectively. Two year OS was 71%. The presence and type of pleural contact was not associated with any of the studied outcomes. CONCLUSION: The presence, type and length of pleural contact as surrogate for visceral pleural invasion were not predictive for outcome. Further studies focussing on risk factors for occult nodal involvement, (I)RR, distant metastases and mortality in early stage NSCLC are warranted for the development of risk adapted diagnostic, treatment and follow-up strategies as more younger, operable and fitter patients receive SABR.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Wink KCJ, Löck S, Rossi M, et al. Contact of a tumour with the pleura is not associated with regional recurrence following stereotactic ablative radiotherapy for early stage non-small cell lung cancer. Radiother Oncol. 2018. PMID: 30773178. doi:10.1016/j.radonc.2018.11.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。